Review ArticleReview
Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors
Pekka T. Männistö and Seppo Kaakkola
Pharmacological Reviews December 1999, 51 (4) 593-628;
Pekka T. Männistö
Seppo Kaakkola
You do not have access to the full text of this article, the first page of the PDF of this article appears above.
PharmRev articles become freely available 12 months after publication, and remain freely available for 5 years.
Thank you for sharing this Pharmacological Reviews article.
You are going to email the following Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors
Message Subject (Your Name) has forwarded a page to you from Pharmacological Reviews
Message Body (Your Name) thought you would be interested in this article in Pharmacological Reviews.
Pharmacological Reviews December 1, 1999, 51 (4) 593-628;
II. COMT Gene and Proteins
III. COMT Inhibitors
IV. Positron Emission Tomography Studies
V. Practical and Theoretical Clinical Uses of COMT Inhibitors
VI. Human Studies with COMT Inhibitors
VII. Summary
VIII. Future Aspects
Induction of Drug Metabolism: The Role of Nuclear Receptors
International Union of Pharmacology. XXXIX. Compendium of Voltage-Gated Ion Channels: Sodium Channels
International Union of Pharmacology. XL. Compendium of Voltage-Gated Ion Channels: Calcium Channels
Show more REVIEW
About Pharmacological Reviews